Atlas Trials

Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China

Clinical trial NCT04421495 · UNKNOWN

Trial details

NCT number
NCT04421495
Sponsor
Beijing Chest Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Multidrug Resistant Tuberculosis
Start date
2020-07-16
Primary completion
2022-06-16
Enrollment
608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.